Evaluating pre- and post-operation plasma miRNAs of papillary thyroid carcinoma (PTC) patients in comparison to benign nodules

Table 4 Relation between miRs and demographic, clinical and pathologic findings in both groups

		miR-222		miR-181a		miR-155-5-P		miR-146a
		Pre-op	Post-op	Pre-op	Post-op	Pre-op	Post-op	Pre-op	Post-op
Age	Case	0.95	0.96	0.20	0.46	0.32	0.28	0.41	0.60
Age	Control	0.67	0.10	0.01	0.05	0.60	0.67	0.43	0.41
Lymphadenectomy	Case	0.25	0.10	0.42	0.46	0.30	0.24	0.28	0.14
Lymphadenectomy	Control
Lymph node involvement	Case	0.24	0.31	0.59	0.28	0.50	0.45	0.32	0.09
Lymph node involvement	Control
Sex	Case	0.03	0.46	0.006	0.12	0.42	0.50	0.20	0.16
Sex	Control	0.18	0.41	0.08	0.05	0.39	0.32	0.27	0.49
Size	Case	0.95		0.04		0.38		0.78
Size	Control	0.32		0.65		0.13		0.14
BRAFV600E	Case	< 0.001	0.98	0.60	0.64	0.30	0.30	< 0.001	< 0.001
BRAFV600E	Control	0.22	0.86	0.60	0.52	0.32	0.32	0.18	0.18
Capsular involvement	Case	0.15	0.66	0.09	0.83	0.11	0.11	0.71	0.80
Capsular involvement	Control	0.27	0.13	0.26	0.24	0.59	0.52	0.04	0.01
Involved lobe of thyroid	Case	0.66	0.28	0.71	0.36	0.47	0.47	0.57	0.62
Involved lobe of thyroid	Control	0.72	0.45	0.87	0.02	0.43	0.40	0.96	0.87

All P-values were obtained by Mann-Whitney U test, whereas the significant findings are italic

ISSN: 1471-2407